Drug commercialization company Medical Knowledge Group acquired by Novo Holdings

The life science investor has started 2022 with an acquisition.

Photo: Novo Holdings / PR

Novo Holdings has acquired US-based Medical Knowledge Group, which has developed a platform for launching new drugs.

In a press release on Monday morning, Novo Holdings did not reveal the size of the investment, but stated it was completed by its principal investment arm.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs